Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25712477.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 EMBO+J 2015 ; 34 (7): 856-80 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Autophagy in malignant transformation and cancer progression #MMPMID25712477
Galluzzi L; Pietrocola F; Bravo-San Pedro JM; Amaravadi RK; Baehrecke EH; Cecconi F; Codogno P; Debnath J; Gewirtz DA; Karantza V; Kimmelman A; Kumar S; Levine B; Maiuri MC; Martin SJ; Penninger J; Piacentini M; Rubinsztein DC; Simon HU; Simonsen A; Thorburn AM; Velasco G; Ryan KM; Kroemer G
EMBO J 2015[Apr]; 34 (7): 856-80 PMID25712477show ga
Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells, such a homeostatic activity constitutes a robust barrier against malignant transformation. Accordingly, many oncoproteins inhibit, and several oncosuppressor proteins promote, autophagy. Moreover, autophagy is required for optimal anticancer immunosurveillance. In neoplastic cells, however, autophagic responses constitute a means to cope with intracellular and environmental stress, thus favoring tumor progression. This implies that at least in some cases, oncogenesis proceeds along with a temporary inhibition of autophagy or a gain of molecular functions that antagonize its oncosuppressive activity. Here, we discuss the differential impact of autophagy on distinct phases of tumorigenesis and the implications of this concept for the use of autophagy modulators in cancer therapy.